Bola Tayo

发表

Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate – a randomized, parallel group, phase 2, colonoscopist-blinded trial

M. Halphen, L. Clayton, Rüdiger Kornberger, 2019, BMC Gastroenterology.

A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment

Gilmour Morrison, F. Sahebkar, Bola Tayo, 2019, Clinical Pharmacokinetics.

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy

E. Ben-Menachem, B. Gunning, K. VanLandingham, 2020, CNS Drugs.

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

B. Gidal, Gilmour Morrison, Bola Tayo, 2018, CNS Drugs.

A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment

Gilmour Morrison, Bola Tayo, Julie Crockett, 2019, Journal of clinical pharmacology.

A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects

D. Critchley, J. Berwaerts, Gilmour Morrison, 2020, Epilepsia.

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

J. Panse, M. Sabel, R. Fietkau, 2021, British Journal of Cancer.

Abrupt withdrawal of cannabidiol (CBD): A randomized trial

K. Sommerville, Bola Tayo, Julie Crockett, 2020, Epilepsy & Behavior.

Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial

C. Fairhurst, Ram Kumar, Bola Tayo, 2020, Developmental medicine and child neurology.

Pharmacokinetic Drug-Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial.

Cuiping Chen, D. Critchley, J. Berwaerts, 2023, Clinical pharmacology in drug development.

A Phase 1 Open‐Label, Fixed‐Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects

D. Critchley, Ching Thai, Bola Tayo, 2021, Clinical pharmacology in drug development.

Pharmacodynamic and Clinical Evaluation of Low-Volume Polyethylene Glycol (PEG)-Based Bowel Cleansing Solutions (NER1006) Using Split Dosing in Healthy and Screening Colonoscopy Subjects: 655

S. Flanagan, M. Halphen, L. Clayton, 2014 .